We are live on ! Find out more
CMLFU

CM Life Sciences, Inc. Unit
CMLFU

Delisted

CMLFU was delisted on the 22nd of July, 2021.

Back to rankings

58 hedge funds and large institutions have $393M invested in CM Life Sciences, Inc. Unit in 2020 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+58
Holders Change %
–
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
58
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SHCM
Sachem Head Capital Management
New York
+$36.5M
2
MF
Magnetar Financial
Illinois
+$33.7M
3
Millennium Management
Millennium Management
New York
+$27.7M
4
BCM
BlueCrest Capital Management
Jersey
+$26.3M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$22.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SHCM
1
Sachem Head Capital Management
New York
$36.3M +$36.5M +3,465,000 New
MF
2
Magnetar Financial
Illinois
$33.5M +$33.7M +3,200,000 New
BCM
3
BlueCrest Capital Management
Jersey
$26.2M +$26.3M +2,500,000 New
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$22.5M +$22.6M +2,147,854 New
LA
5
Linden Advisors
New York
$22M +$22.1M +2,100,000 New
WMSA
6
Weiss Multi-Strategy Advisers
New York
$21.9M +$22.1M +2,096,114 New
Blackstone Inc
7
Blackstone Inc
New York
$16.5M +$16.6M +1,575,000 New
YCMGA
8
York Capital Management Global Advisors
New York
$15.7M +$15.8M +1,500,000 New
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$15.7M +$15.7M +1,495,000 New
DKCM
10
Davidson Kempner Capital Management
New York
$15.6M +$15.8M +1,500,000 New
KC
11
Kepos Capital
New York
$11.2M +$11.2M +1,066,858 New
BCP
12
Berylson Capital Partners
Massachusetts
$10.5M +$10.5M +1,000,000 New
MCM
13
Moore Capital Management
New York
$10.5M +$10.5M +1,000,000 New
TCIM
14
TOMS Capital Investment Management
New York
$10.5M +$10.5M +1,000,000 New
WAM
15
Weiss Asset Management
Massachusetts
$10.5M +$10.5M +1,000,000 New
SRCM
16
Sage Rock Capital Management
New York
$8.9M +$8.94M +850,000 New
AA
17
AQR Arbitrage
Connecticut
$8.58M +$8.63M +819,844 New
6CM
18
683 Capital Management
New York
$7.85M +$7.89M +750,000 New
CCA
19
Castle Creek Arbitrage
Colorado
$7.85M +$7.9M +751,100 New
IM
20
Islet Management
New York
$7.85M +$7.89M +750,000 New
SC
21
Sculptor Capital
New York
$5.99M +$6.02M +571,756 New
MC
22
Maverick Capital
Texas
$5.52M +$5.54M +526,970 New
AIMCA
23
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$5.24M +$5.26M +500,000 New
GL
24
Governors Lane
New York
$5.24M +$5.26M +500,000 New
GS
25
Gagnon Securities
New York
$4.76M +$4.78M +454,204 New
1
2 3

CMLFU Hedge Fund Activity: Q3 2020 in Review

58 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences, Inc. Unit (CMLFU) for Q3 2020, worth a combined $393M.

Buyers outnumbered sellers: 58 funds opened new CMLFU positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sachem Head Capital Management, opening a new position worth an estimated $36.5M.

  • 58 institutional investors held CM Life Sciences, Inc. Unit (CMLFU) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $393M of CM Life Sciences, Inc. Unit stock for Q3 2020.
  • 58 funds opened new CM Life Sciences, Inc. Unit positions in Q3 2020 and 0 closed out, a net change of +58 holders.
  • The largest CM Life Sciences, Inc. Unit buyer in Q3 2020 was Sachem Head Capital Management, an estimated $36.5M added.

Based on aggregated 13F filings for Q3 2020.